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Abstract: A bone-implanted porous scaffold of mesoporous bioglass/polyamide composite 
(m-BPC) was fabricated, and its biological properties were investigated. The results indicate 
that the m-BPC scaffold contained open and interconnected macropores ranging 400–500 µm, 
and exhibited a porosity of 76%. The attachment ratio of MG-63 cells on m-BPC was higher 
than polyamide scaffolds at 4 hours, and the cells with normal phenotype extended well when 
cultured with m-BPC and polyamide scaffolds. When the m-BPC scaffolds were implanted into 
bone defects of rabbit thighbone, histological evaluation confirmed that the m-BPC scaffolds 
exhibited excellent biocompatibility and osteoconductivity, and more effective osteogenesis 
than the polyamide scaffolds in vivo. The results indicate that the m-BPC scaffolds improved 
the efficiency of new bone regeneration and, thus, have clinical potential for bone repair.
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Introduction
Bioactive glasses (BGs) with excellent biocompatibility and bioactivity have been used 
for bone tissue repair since their discovery some decades ago.1,2 In 2004, a significant 
evolution in this field was developed by Yan et al who synthesized, for the first time, 
BG that showed an ordered mesoporous arrangement, and the inclusion of mesopores 
in silicon dioxide-calcium oxide-phosphorus pentoxide-based glasses opened a wide 
range of new potential applications for BG.3
Mesoporous BG (m-BG) shows the outstanding textural properties of   classical 
silica-based mesoporous materials such as MCM-41 and SBA-15, that is, high surface 
area and pore volume, and well-defined mesoporous diameter.4,5 The large surface area 
of m-BG results in higher chemical reactivity compared to that of BG. The existence 
of mesoporosities in the BG matrixes and their high surface area greatly accelerate 
the deposition process of hydroxycarbonate apatite as demonstrated by Zhao et al.6 
Thus, bioactive kinetics are enhanced, which improves the role of   silica-based BG 
as devices for bone tissue regeneration. In this sense, several groups have proposed 
m-BG as components of scaffolds for bone tissue engineering.7–9 Although the   existing 
bioactive inorganic materials (such as BG) possess excellent bioactivity, they are very 
brittle and have inherently poor tensile properties.10,11 Polymers such as poly(lactic 
acid),   polyglycolide, and poly(lactide-co-glycolide) have been widely used to   fabricate 
  different types of scaffolds for bone repair, owing to their biocompatibility and   malleable 
nature.12 Nevertheless, there are limits to the practical use of these   polymers for bone 
replacement. For example, none of the polymers mentioned above are bioactive, 
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which means that the newly formed bone   tissue cannot bond 
tightly to the polymer surface.13 Given the   limitations and 
advantages of bioactive inorganic   materials and polymers, 
the application of polymers and bioactive materials to cre-
ate a bioactive composite scaffold was   suggested, and many 
studies have demonstrated composite scaffolds with physical, 
biological, and mechanical properties suitable for bone tissue 
engineering application.14–16
Tissue engineering offers a promising new approach to 
bone repair. Successful bone tissue engineering requires the 
use of a porous scaffold with interconnected spaces in order 
to provide sufficient room for cell migration and adhesion, 
and the ingrowth of new bone tissue.17,18 Polyamide (PA), 
a polymer with excellent biocompatibility, has been used 
to fill bone defects and to create porous scaffolds for bone 
tissue engineering.19 Poly(lactic acid), or polyglycolide and 
poly(lactide-co-glycolide), show a collapse degradation man-
ner after implanted in vivo, and also give rise to acid degrada-
tion by-products, stimulation to tissue, and even inflammation, 
while PA does not have these disadvantages.12 In this study, a 
novel porous scaffold of m-BG and PA6 composite (m-BPC) 
was fabricated, and its properties were investigated.
Material and methods
Preparation of m-Bg
m-BG was synthesized by using nonionic block copolymer 
EO20PO70EO20 (Pluronic P123, Boston, USA) (Sigma-
aldrich, Shanghai Trading Co., Ltd, Shanghai, China) as 
the template agent,4 and tetraethyl orthosilicate (Sinopharm 
Chemical Reagent Co., Ltd, Shanghai, China) as the silica 
source. P123 (8 g) was dissolved in 120 mL ethanol under 
stirring for 2 hours, and 13.4 g of tetraethyl orthosilicate 
and 4 g of 1M hydrochloride (Sinopharm Chemical 
Reagent Co., Ltd, Shanghai, China) were added to the 
mixed solution of P123 and ethanol. Then, 2.8 g of calcium 
nitrate tetrahydrate (Sinopharm Chemical Reagent Co., 
Ltd, Shanghai, China) and 1.46 g of triethyl phosphate 
(Sinopharm Chemical Reagent Co., Ltd, Shanghai, China), 
with a molar ratio of 1:1.5 calcium:phosphorus, were added 
as calcium and phosphorus oxide precursors, respectively, 
and stirred magnetically at room   temperature for 24 hours. 
The precipitation was filtered, washed thoroughly with 
deionized water, and dried at 60°C under vacuum (DIF-
6020, Shanghai Jinghong laboratory equipment Co., Ltd, 
Shanghai, China) to get the powders. The samples were 
sintered at 600°C for 6 hours with a heating rate of 1°C/
min to remove the template (P123) and obtain m-BG. 
Scanning electron microscopy (SEM) (JSM-6360 LV; 
JEOL Ltd, Tokyo, Japan) and high resolution transmission 
electron microscopy (TEM) (JEM-2010; JEOL) was used to 
characterize the morphology and microstructure of m-BG. 
Brunauer–Emmett–Teller and Barrett–Joyner–Halenda 
analyses with a porosimeter (TriStar® 3000; Micromeritics 
Instrument Corporation, Norcross, GA) were used to deter-
mine the surface area and the pore size distribution.
Preparation of m-BPC scaffolds
The m-BPC scaffolds were prepared by solvent casting and 
particulate leaching. Briefly, 9 g of PA6 (Bayer Durethan® 
B30S, Leverkusen, Germany) was dissolved in 50 mL calcium 
chloride/ethanol solution at a   concentration of 20% (weight/
volume), and 3 g m-BG was added to produce an m-BG/PA 
composite with 25 weight percent m-BG   content. The mixture 
was stirred continuously for 2 hours, and sodium chloride 
was added as a porogen (size: 400–500 µm: PA/sodium 
chloride = 1/8, weight/weight), and the mixture was cast into 
Teflon molds containing 60 wells (Institute of biomaterials, 
Shanghai, China) (Φ 10 × 5 mm). The samples were air-dried 
in a fume hood (Institute of Biomaterials, Shanghai, China) 
for 24 hours to evaporate the ethanol and were subsequently 
vacuum-dried at 50°C for 48 hours to remove any remaining 
solvent. To leach out the salt, the dry samples were immersed 
in deionized water for 48 hours at room temperature, with 
water changes approximately every 12 hours three or four 
times. The scaffolds were obtained by removing from the 
water and air-drying for 24 hours. Using the same method, 
pure PA scaffolds were prepared as a control. The morphology 
of m-BPC scaffolds were observed by SEM (JSM-6360LV; 
JEOL). The porosity of the m-BPC scaffolds was measured 
in distilled water using Archimedes method.
Cell attachment
To investigate the attachment properties of MG-63 cells 
(Chinese Academy of Sciences Shanghai cell library, 
Shanghai, China) on the m-BPC scaffolds (PA as a control), 
the samples (Φ 10 × 5 mm) were sterilized using ultraviolet 
light. MG-63 cells were seeded on the samples at a density 
of 5 × 103 cells/per sample. Adhesion cells on substrates were 
assessed quantitatively using a 3-(4,5- dimethylthiazol-2-yl)-
2,5-diphenyltetrazolium bromide (MTT) assay (MTT Kit; 
Roche Diagnostics, Indianapolis, IN). In brief, cells/scaffold 
construct was placed in a culture medium containing MTT and 
incubated in a humidified atmosphere at 37°C for 4 hours. The 
absorbance value was measured at 570 nm using a Multiskan 
MK3 microplate reader (Thermoelectric, Shanghai, China). 
Six specimens were tested at each incubation period, and 
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each test was performed in triplicate. Results are reported 
as optical density units. The morphologies of cells cultured 
with both m-BPC and PA scaffold samples were observed 
and photographed under an inverted light microscope 
(IMT-2, A10PL; Olympus Corporation, Tokyo, Japan).
Surgical procedures
The study was approved by the Laboratory Animal Center 
of Shanghai University of Traditional Chinese Medi-
cine (Shanghai, China). A study in a rabbit femur cavity 
defect model was carried out to investigate the efficacy 
of composite scaffolds in promoting bone repair. Twenty-
four skeletal mature New Zealand white rabbits (Silaike 
Inc. Shanghai, China) were used in this study, and surgi-
cal intervention was performed under general anesthesia. 
Lateral and medial approaches were performed in left 
shaved knees to expose the distal femoral epiphysis, and 
the cavitary defects were created with a medium speed 
burr (Φ 5 × 5 mm). After the defects were washed with 
physiological saline, the m-BPC and PA scaffolds were 
implanted; the empty bony defects served as the control. 
At 4 weeks and 12 weeks after implantation, the rabbits 
were sacrificed with an overdose of pentobarbital and the 
bone formation was evaluated with synchrotron radiation-
based microcomputed tomography (SR m-CT) BL13W1, 
Shanghai Synchrotron Radiation Facility. Shanghai, China 
scan images. The implants were then retrieved with the 
surrounding tissues and prepared for histological analysis.
SR m-CT imaging and histological analysis
SR m-CT was used to evaluate repair of the bone defect by 
composite scaffolds, which were performed at beamline 
BL13W (Shanghai Synchrotron Radiation Facility, Shanghai, 
China) using a monochromatic beam with an energy of 30 keV 
and a sample-to-detector distance of 1.5 m. A 4000 × 2500 
charge-coupled device detector, (CCD, Double Asahi 
Electronics Co., Ltd, Shanghai, China), with the pixel size set 
to 6 mm, was used to record images. A total of 1200 projec-
tions within an angular range of 180°C were taken, and the 
exposure time amounted to 8 seconds per projection. The 
three-dimensional structure was reconstructed using a filtered 
back-projection algorithm. The images were finally redigitized 
with an 8-bit data format, proportional to the measured attenu-
ation coefficients of the voxels. Bone radiomorphometric anal-
ysis was performed by using MicroView 2.2 Advanced Bone 
Analysis Application software (GE Healthcare, Waukesha, 
WI). The amount of bone ingrowth into the scaffolds was 
quantified as the bone volume within the defined volume of 
interest in each bone defect site.
At the end of each implantation period, femora were 
removed and assigned to histological analysis. After fixa-
tion with 4% neutral buffered formalin for 48 hours, the 
extracted femora were decalcified in 12.5% ethylenedi-
aminetetraacetic acid (Sinopharm Chemical Reagent Co., 
Ltd, Shanghai, China), dehydrated in a graded series of 
alcohol, and embedded in paraffin. Serial 4-mm thick sec-
tions were then stained with hematoxylin and eosin (The 
Tianjin Bankee Biotechnology Co., Ltd,Tianjin,China) and 
observed microscopically.
Statistical analysis
All quantitative data were analyzed with Origin® 8.0 
(OriginLab Corporation, Northampton, MA) and expressed as 
mean and standard deviation. Statistical analysis was carried 
out using analysis of variance. Statistical significance was 
attained with greater than 95% confidence level (P , 0.05).
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Figure 1 (A) Scanning electron microscopic and (B) transmission electron microscopic images of the morphology of mesoporous bioactive glass. 
Note: Arrow represents mesoporous channels.
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Morphology and microstructure  
of m-BPC scaffolds
Figure 3 shows a photo of m-BPC scaffolds. Figure 4 shows 
the SEM images of the surface morphology and microstructure 
of the m-BPC porous scaffolds under various   magnifications. 
The m-BPC scaffolds exhibited a macroporous structure with 
completely open interconnected pores. The pores appeared 
almost spherical in shape, with diameters of 400–500 µm 
(Figure 4A). High-magnification SEM images further 
revealed that a number of small pores (around 2 µm) were 
distributed across the macropore walls. The   porosity of the 
m-BPC scaffolds prepared by this method was around 76%.
Cell attachment and morphology
Cell attachment was investigated using the MTT assay 
of MG-63 cells cultured on m-BPC scaffold samples; PA 
scaffolds and tissue culture plate were used as controls. 
Figure 5 shows the results of the optical density values 
(represents cell attachment ratio) for these scaffold samples. 
At 4 hours, the optical density values for m-BPC were 
  significantly higher than PA and the control (P , 0.05). 
These results indicate that cell attachment for m-BPC was 
superior to PA samples, suggesting that m-BPC facilitated 
cell adhesion on its surfaces.
Morphologies of MG-63 cells cultured with m-BPC and 
PA scaffold samples were observed using phase contrast 
microscopy, as shown in Figure 6. The micrographs reveal 
that after being cultured for 4 hours, MG-63 cells cultured 
with both m-BPC and PA specimens grew well and stretched 
sufficiently, had full configurations, and showed no abnormal 
morphologies. These results indicate that both m-BPC and PA 
scaffolds had no negative effect on MG-63 cell morphology 
and viability, and both provide good cytocompatibility.
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Figure 2 (A) Nitrogen gas sorption isotherms and (B) pore size distribution of mesoporous bioactive glass.
Figure 3 Photo of mesoporous bioactive glass and polyamide composite scaffolds.
Results
SEM and TEM analysis
SEM and TEM images of the m-BG are shown in Figure 1. 
Approximate sphere-like m-BG particles with a size of 
0.1–1 µm are shown as an SEM image in Figure 1A. In the 
TEM image, it was found that homogeneously distributed 
mesopore channels appeared in the BG particle (shown as 
white line; Figure 1B).
Brunauer–Emmett–Teller analysis
The sorption isotherms and pore size distribution of m-BG 
are shown in Figure 2. The results show that the specific 
surface area and average pore size of m-BG were 439 m2 g−1 
and 7 nm, respectively. The nitrogen adsorption-desorption 
isotherm of the m-BG exhibited type IV adsorption behavior, 
which indicates capillary condensation in mesopores. The 
results indicate that the prepared m-BG had a mesoporous 
structure.
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Implantation of m-BPC scaffolds in vivo
Macroscopic and SR m-CT evaluation
Figure 7 shows the macroscopic evaluation of the m-BPC 
scaffolds implanted in the bone cavities of rabbit femora 
for 4 weeks and 12 weeks. At 4 weeks, abscission of the 
suture occurred and the surface of the bone defects was 
  partially filled with callus bone. At 12 weeks, the bone 
defects were repaired by implanted scaffolds; the wounds 
healed well without dehiscence and did not elicit any obvious 
inflammatory response in the adjacent soft tissue. No signs 
of implant rejection, necrosis, or infection were found at the 
experimental time.
The m-BPC scaffolds implanted into bone defects of 
rabbit femora were scanned by SR m-CT at 4 weeks and 
12 weeks to evaluate the in vivo bone ingrowth of m-BPC 
scaffolds (Figure 8). At 4 weeks, the three-dimensional SR 
m-CT images revealed that only a small amount of newly 
formed bone appeared in the m-BPC scaffolds at the native 
bone margins and the defect periphery throughout the cross-
section of the bone defect. At 12 weeks, the most extensive 
bone ingrowth was observed throughout the entire volume of 
the m-BPC scaffolds, and the formation of new bone tissue 
was observed as well.
Histological analysis
Histological analysis of the m-BPC scaffolds implanted 
into bone defects of rabbit femora, as shown in Figure 9, 
enabled a more detailed analysis on the new bone tissue 
formation inside the m-BPC scaffolds. At 4 weeks, new 
bone formation was found around the scaffold materials in 
the vicinity of bone marrow. This newly formed bone had a 
more trabecular appearance with osteoid depositions at the 
surface of the scaffold materials (Figure 9A). After 12 weeks, 
newly formed bone was predominant in the healing area and 
woven bone was replaced by mature trabecular bone. New 
bone formation (bone ingrowth) in the m-BPC scaffolds was 
more extensive (Figure 9B), which was consistent with SR 
m-CT analysis.
Figure 10 shows the regenerated bone volume within the 
bone defect, which was used to evaluate the repair effects of 
bone defects after m-BPC and PA scaffolds implanted for 
4 weeks and 12 weeks. The results indicate that a significant 
increase in bone volume was observed for both m-BPC 
and PA scaffolds from 4 weeks to 12 weeks. In addition, 
the m-BPC scaffolds contained higher bone volume than 
the PA scaffolds (control) at both 4 weeks and 12 weeks 
(P , 0.05).
Discussion
Recently, supramolecular chemistry has allowed the emergence 
of a new generation of advanced mesoporous biomaterials with 
high surface area, high porosity, and uniform pore channels, 
which show enhanced bioactivity and have potential for use in 
the fabrication of porous scaffolds for bone regeneration.20,21 In 
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Figure 5 Attachment of Mg-63 cells on mesoporous bioactive glass and polyamide 
composite  scaffolds.  Polyamide  scaffolds  and  tissue  culture  plate  were  used  as 
controls. Cell attachment is compared to the tissue culture plate control (100%). 
Notes: *Statistical analysis: cell attachment ratio for m-BPC were significantly higher 
than PA and the control (P , 0.05)
Abbreviations:  m-BPC,  mesoporous  bioactive  glass  and  polyamide  composite; 
PA6, polyamide 6; TCP, tissue culture plate.
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Figure 4 Scanning electron microscopic photographs of mesoporous bioactive glass and polyamide composite scaffolds at (A) ×50 and (B) ×5000 magnification.
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Figure 7 Macroscopic evaluation of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A) 4 weeks and 
(B) 12 weeks. 
Note: Circle and arrow show the bone defect area site.
AB
Figure 6 Phase contrast microscopic photographs of Mg-63 cells cultured with (A) mesoporous bioactive glass and polyamide composite scaffolds and (B) and polyamide 
scaffolds for 4 hours.
this study, m-BG were fabricated by using the sol-gel method 
and P123 as a template agent. The surface area and average 
pore size of the m-BG were 439 m2 g-1 and 7 nm, respectively. 
Previous studies have shown that increasing the surface area 
of the biomaterials might greatly accelerate the kinetic process 
of apatite deposition and, therefore, enhance bone-forming 
bioactivity.22
There have been a number of studies in the literature 
focusing on the composites created by combining polymers 
and bioactive inorganic biomaterials.23–25 To the best of the 
authors’ knowledge, there was no previous report about 
the preparation of m-BPC scaffolds used for bone repair 
  material. It is expected that if the synthesis of m-BG has a 
high surface area, the bioactivity of the composite scaffolds 
should be improved. Therefore, the m-BPC scaffolds were 
prepared, and its biological properties were investigated in the 
  current study. An ideal scaffold for bone repair should possess 
appropriate architecture and properties to provide a biological 
environment for cell attachment and cell/tissue ingrowth.26,27 
The m-BPC scaffolds, containing 25 weight percent m-BG 
content with 76% porosity, exhibited interconnected porous 
network and large pore sizes (400–500 µm), which might 
meet the demand of the porous structure. The mesoporous 
material of m-BG in the composite might greatly increase 
the surface area of scaffold materials, which is favorable for 
cell extension and, thus, facilitates repopulating the entire 
bone defect with cells.
Cell attachment belongs to the first phase of cell/material 
interactions, which influences cell growth and morphology 
and proliferates upon contact with the biomaterials.28 In 
the current study, an MTT assay was used to assess the 
relative number of cells that adhered to the m-BPC scaffold 
materials because optical density absorbance values can be 
used as indicators of the relative number of cells attached on 
substrate materials. The results show that the MG-63 cells 
adhered better to the m-BPC scaffolds than the PA scaffolds 
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Figure 8 Synchrotron radiation-based microcomputed tomography of a three-dimensional reconstruction of cross-section images of mesoporous bioactive glass and 
polyamide composite scaffolds implanted into bone defects of rabbit femora for (A) 4 weeks and (B) 12 weeks.
Note: Circle and arrow show the bone defect area site.
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Figure 9 Hematoxylin and eosin stained section of mesoporous bioactive glass and polyamide composite scaffolds implanted into bone defects of rabbit femora for (A and B) 
4 weeks (×5 and ×20, respectively) and (C and D) 12 weeks (×5 and ×20, respectively).
Notes: B represents the new bone tissue, M represents the biomaterials.
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and tissue culture plate within the first 4 hours of culture. 
The enhancement of MG-63 attachment on m-BPC is likely 
associated with its material surface features, such as pore 
size, surface adsorption ability, and protein adsorption of 
the scaffolds in cell culture medium. The m-BPC may have 
special surface properties, due to the addition of m-BG into 
PA, that promote cell attachment.
The in vivo biocompatibility of the m-BPC scaffolds was 
determined by implantation of the scaffold materials into 
bone defects of rabbit femora. SR m-CT imaging results 
show the interactions between the m-BPC scaffolds and 
the surrounding tissues at 4 weeks and 12 weeks; the bone 
regeneration process began soon after implantation, indicating 
that the scaffolds created an environment more conducive for 
bone regeneration.
Another structural property favorable to the osteogenic 
capacity of m-BPC scaffolds may be related to their 
  mesoporous texture. The mesoporous structure provides a 
larger specific area and faster dissolution rate compared to 
traditional melt-derived BGs.29 As most of the mammalian 
cells are anchorage dependent, the mesoporous matrix also 
facilitates peptide adsorption onto the external surface 
of m-BPC scaffolds after implantation, making it more 
accessible to the osteoblastic cell microenvironment 
that provides a protein-rich surface for cell attachment, 
differentiation, and migration to form new tissues.30 The 
morphology of the interface between the m-BPC scaffolds 
and host bone tissue after implantation for 4 weeks and 
12 weeks was observed by histological evaluation. The 
results show that new bone tissue was found to extend along 
the m-BPC scaffolds’ surface and grow into the pores of the 
scaffolds. The results demonstrate that the m-BPC scaffolds 
had excellent biocompatibility and osteoconductivity, and 
could repair the bone defects.
As the implantation time prolonged, new bone   tissue 
regenerated and gradually penetrated into the m-BPC   scaffolds. 
The area of newly formed bone gradually increased with 
time: 31% and 79% of the bone defect area were separately 
filled with newly formed bone tissue after m-BPC scaf-
fold implantation at 4 weeks and 12 weeks, respectively, 
indicating that the hierarchically mesoporous-macroporous 
structure with large surface area could promote m-BPC 
  osteogenesis. However, the area of newly formed bone was 
18% and 47% after PA scaffold implantation at 4 weeks and 
12 weeks, respectively. The results demonstrate that the m-BPC 
scaffolds exhibited high efficiency of bone   regeneration. 
Clearly, the m-BPC had good bioactivity by incorporation 
of m-BG into PA compared to PA scaffolds. In short, the 
  characteristics of m-BPC scaffolds enhanced their bioperfor-
mance, and they showed good biocompatibility as well as faster 
and more effective osteogenesis than PA scaffolds.
Conclusion
The m-BPC scaffolds, shown to have 76% porosity and 
macroporous structure with large (400–500 µm) open 
interconnecting pores, were fabricated for the current study. 
The results show that the incorporation of m-BG into PA to 
form m-BPC scaffolds improved the cell attachment ratio 
compared to PA scaffolds. By using SR m-CT imaging 
and histological analysis, it was found that new bone tissue 
regenerated and gradually penetrated into the m-BPC   scaffolds, 
and 79% of the bone defect area was filled with newly formed 
bone tissue 12 weeks after m-BPC implantation. The results 
indicate that the m-BPC scaffolds significantly promoted repair 
of the bone defect in the rabbit femur model and exhibited high 
efficiency of bone regeneration. In short, the m-BPC scaffolds 
present not only good biocompatibility, but also faster and 
more effective osteogenesis than PA scaffolds.
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